Also published in ncbi.nlm.nih.gov:
Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors.
x hide permanently

Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.

ncbi.nlm.nih.gov

Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.

Eur J Nucl Med Mol Imaging. 2017 Oct 17;:

Authors: Gains JE, Sebire NJ, Moroz V, Wheatley K, Gaze MN

Abstract PURPOSE: Neuroblastoma may be treated with molecular radiotherapy, (131)I meta-Iodobenzylguanidine and (177)Lu Lutetium DOTATATE, directed at distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2), respectively.

Mentions: Radiotherapy Imaging MYCN